Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 54,90€(+14.837.737,84%). Der Median liegt bei 60,47€(+16.343.143,24%).
Kaufen | 6 |
Halten | 3 |
Verkaufen | 0 |
Scoring-Modelle
Dividenden-Strategie | 0 / 15 |
HGI-Strategie | 3 / 18 |
Levermann-Strategie | -6 / 13 |
News
Taiwan's EVA Air activates NDC connection with Sabre
The addition of EVA Air advances Sabre's multi-source content strategy by expanding booking options for travel agencies SOUTHLAKE, Texas and SINGAPORE and TAIPEI CITY, Taiwan , Nov. 21, 2024 /PRNewswire/ -- Sabre Corporation (NASDAQ: SABR), a leading software and technology provider that powers the global travel industry, today announced New Distribution Capability (NDC) connectivity from Star Alliance member and five-star SKYTRAX airline, EVA Air, through Sabre's global multi-source content platform. With this new connection, EVA Air's NDC content will be seamlessly integrated into Sabre's global distribution system (GDS), allowing travel agencies and corporate buyers to compare flight options with greater efficiency and transparency.» Mehr auf prnewswire.com
Eli Lilly to license arthritis drug to Egypt's EVA Pharma
Eli Lilly and Egypt's EVA Pharma have entered into an agreement to license Lilly's rheumatoid arthritis drug in 49 countries in Africa, the companies said on Wednesday.» Mehr auf reuters.com
Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries
Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases across 49 low- to middle-income countries in Africa INDIANAPOLIS and CAIRO , Sept. 4, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and EVA Pharma announced today that the companies have entered into an agreement to expand access to baricitinib to an estimated 20,000 people in 49 low- to middle-income countries in Africa by 2030.» Mehr auf prnewswire.com
Historische Dividenden
Alle DividendenKennzahlenUnternehmenszahlen
(EUR) | Dez. 2023 | |
---|---|---|
Umsatz | 282,87 Mio | - |
Bruttoeinkommen | −243,59 Mio | - |
Nettoeinkommen | −387,22 Mio | - |
EBITDA | −288,38 Mio | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 30,02 Mio€ |
Anzahl Aktien | 74,50 Mio |
52 Wochen-Hoch/Tief | 6,50€ - 0,24€ |
Dividenden | Nein |
Beta | 0,84 |
KGV (PE Ratio) | −0,05 |
KGWV (PEG Ratio) | 0,00 |
KBV (PB Ratio) | −0,26 |
KUV (PS Ratio) | 0,03 |
Unternehmensprofil
Name | Enviva Partners |
CEO | Glenn T. Nunziata |
Sitz | Bethesda, md USA |
Mitarbeiter | 1.234 |
Ticker Symbole
Börse | Symbol |
---|---|
NYSE | EVA |
Assets entdecken
Shareholder von Enviva Partners investieren auch in folgende Assets